Page last updated: 2024-08-16

sulfanilamide and acetazolamide

sulfanilamide has been researched along with acetazolamide in 133 studies

Research

Studies (133)

TimeframeStudies, this research(%)All Research%
pre-199036 (27.07)18.7374
1990's3 (2.26)18.2507
2000's35 (26.32)29.6817
2010's54 (40.60)24.3611
2020's5 (3.76)2.80

Authors

AuthorsStudies
Briganti, F; Menabuoni, L; Mincione, F; Mincione, G; Scozzafava, A; Supuran, CT2
Briganti, F; Ilies, MA; Scozzafava, A; Supuran, CT1
Menabuoni, L; Mincione, F; Mincione, G; Scozzafava, A; Supuran, CT1
Menabuoni, L; Mincione, F; Scozzafava, A; Supuran, CT1
Franchi, M; Gallori, E; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D1
Caproiu, MT; Ilies, M; Ilies, MA; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D1
Casini, A; Mincione, F; Montero, JL; Scozzafava, A; Starnotti, M; Supuran, CT; Winum, JY1
Antel, J; Franchi, M; Gallori, E; Scozzafava, A; Supuran, CT; Vullo, D1
Jaiswal, M; Khadikar, PV; Scozzafava, A; Supuran, CT1
Casini, A; Lehtonen, JM; Parkkila, S; Scozzafava, A; Supuran, CT; Vullo, D1
Fasolis, G; Garaj, V; Innocenti, A; Montero, JL; Puccetti, L; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY1
Casini, A; Ferry, JG; Innocenti, A; Scozzafava, A; Supuran, CT; Zimmerman, S1
Durgun, M; Emul, M; Innocenti, A; Scozzafava, A; Supuran, CT; Turkmen, H; Vullo, D; Yilmaztekin, S1
Innocenti, A; Kaila, K; Ranki, H; Rivera, C; Scozzafava, A; Supuran, CT; Voipio, J; Vullo, D1
Antel, J; Firnges, MA; Innocenti, A; Scozzafava, A; Supuran, CT; Wurl, M1
Cecchi, A; Fasolis, G; Gamberi, A; Montero, JL; Puccetti, L; Scozzafava, A; Supuran, CT; Winum, JY1
Cecchi, A; Innocenti, A; Montero, JL; Scozzafava, A; Supuran, CT; Winum, JY1
Innocenti, A; Mastrolorenzo, A; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D2
Bacciottini, L; Casini, A; Masini, E; Mincione, F; Scozzafava, A; Scrivanti, C; Starnotti, M; Supuran, CT; Vullo, D1
Arslan, O; Fasolis, G; Ozensoy, O; Puccetti, L; Scozzafava, A; Supuran, CT1
Minakuchi, T; Morimoto, K; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D1
Minakuchi, T; Morimoto, K; Nishimori, I; Onishi, S; Sano, S; Scozzafava, A; Supuran, CT; Takeuchi, H; Vullo, D1
Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D1
Kohsaki, T; Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Takeuchi, H; Vullo, D1
Cecchi, A; Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D1
Innocenti, A; Montero, JL; Rami, M; Scozzafava, A; Supuran, CT; Winum, JY1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Arslan, O; Aydin, M; Guler, OO; Innocenti, A; Isik, S; Kockar, F; Scozzafava, A; Supuran, CT1
Hilvo, M; Innocenti, A; Kulomaa, MS; Parkkila, S; Salzano, AM; Scaloni, A; Scozzafava, A; Supuran, CT1
Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D2
Innocenti, A; Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D1
Hall, RA; Innocenti, A; Mühlschlegel, FA; Schlicker, C; Scozzafava, A; Steegborn, C; Supuran, CT1
Bertucci, A; Innocenti, A; Scozzafava, A; Supuran, CT; Tambutté, S; Zoccola, D2
Carta, F; Covarrubias, AS; Jones, TA; Maresca, A; Mowbray, SL; Supuran, CT1
Davis, RA; Innocenti, A; Poulsen, SA; Supuran, CT1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Innocenti, A; Parkkila, S; Scozzafava, A; Supuran, CT; Temperini, C1
Joseph, P; Köhler, S; Minakuchi, T; Montero, JL; Nishimori, I; Ouahrani-Bettache, S; Scozzafava, A; Supuran, CT; Turtaut, F; Vullo, D; Winum, JY1
Köhler, S; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Arslan, O; Aydin, M; Güler, OO; Işik, S; Kockar, F; Maresca, A; Sinan, S; Supuran, CT; Turan, Y; Turkoglu, S1
Ekins, S; Williams, AJ; Xu, JJ1
Carta, F; Pacchiano, F; Scozzafava, A; Supuran, CT; Vullo, D1
Joseph, P; Köhler, S; Minakuchi, T; Montero, JL; Nishimori, I; Ouahrani-Bettache, S; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY1
Davis, RA; Hall, RA; Hofmann, A; Innocenti, A; Mühlschlegel, FA; Osman, A; Poulsen, SA; Supuran, CT; Vullo, D1
Maresca, A; Montero, JL; Rami, M; Scozzafava, A; Smaine, FZ; Supuran, CT; Winum, JY1
Basar, E; Bülbül, M; Cakir, E; Kaya, M; Tunca, E1
Innocenti, A; Knaus, EE; Scozzafava, A; Supuran, CT1
Alp, C; Alp, NA; Erdem, D; Gültekin, MS; Küfrevioğlu, Öİ; Özsoy, Ş; Şentürk, M; Supuran, CT1
Jackson, DJ; Ohradanova, A; Pastorek, J; Pastorekova, S; Supuran, CT; Vullo, D; Wörheide, G1
Bornaghi, LF; Innocenti, A; Lopez, M; Moeker, J; Poulsen, SA; Rossit, S; Supuran, CT; Teruya, K; Wilkinson, BL1
Alper, M; Arslan, O; Işık, S; Kockar, F; Maresca, A; Ozensoy, O; Sinan, S; Supuran, CT; Turkoglu, S1
Hewitson, KS; Mastrolorenzo, A; Scozzafava, A; Supuran, CT; Vullo, D1
Capasso, C; Carginale, V; Luca, VD; Rossi, M; Scozzafava, A; Supuran, CT; Vullo, D1
Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Isik, S; Scozzafava, A; Supuran, CT; Vullo, D1
Capaci Rodrigues, G; Capasso, C; Pan, P; Parkkila, S; Scozzafava, A; Supuran, CT; Tolvanen, ME; Vermelho, AB1
Capasso, C; Leewattanapasuk, W; Mastrolorenzo, A; Mühlschlegel, FA; Supuran, CT; Vullo, D1
Duan, YT; Qin, YJ; Qiu, HY; Sang, YL; Wang, PF; Wang, YT; Wang, ZC; Wen, Q; Yang, YA; Zhang, X; Zhu, HL1
Capasso, C; Corte-Real, S; Pan, P; Parkkila, S; Rodrigues, Ide A; Salonen, T; Supuran, CT; Syrjänen, L; Vermelho, AB; Vullo, D1
Bozdag, M; Carta, F; Ferraroni, M; Nuti, E; Rossello, A; Scozzafava, A; Supuran, CT; Vullo, D1
Alothman, Z; Capasso, C; De Luca, V; Del Prete, S; Osman, SM; Scozzafava, A; Supuran, CT; Vullo, D2
Balboni, G; Congiu, C; Onnis, V; Supuran, CT1
Barboiu, M; Cristian, A; Nasr, G; Supuran, CT; Vullo, D; Winum, JY1
Capasso, C; Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D1
AlOthman, Z; Capasso, C; Osman, SM; Prete, SD; Scozzafava, A; Supuran, CT; Vullo, D1
Andrews, KT; Capasso, C; Del Prete, S; Fisher, GM; Poulsen, SA; Supuran, CT; Vullo, D1
Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Scozzafava, A; Supuran, CT; Vullo, D2
Kuuslahti, M; Parkkila, S; Supuran, CT; Syrjänen, L; Tolvanen, M; Vullo, D1
Capasso, C; Dedeoglu, N; DeLuca, V; Isik, S; Kockar, F; Supuran, CT; Yildirim, H1
Bhatt, A; Mahon, BP; McKenna, R; Supuran, CT; Vullo, D1
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Osman, SM; Scozzafava, A; Supuran, CT; Vullo, D1
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Ferraroni, M; Osman, SM; Supuran, CT; Vullo, D1
Aşık, A; Beldüz, AO; Çanakçı, S; Çolak, DN; Eminoğlu, A; Supuran, CT; Vullo, D1
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Osman, SM; Supuran, CT; Vullo, D2
Bao, Y; Chang, XW; Cheng, MS; Guo, C; Hou, Z; Lin, B; Liu, Y; Wang, ZJ; Wei, GF; Yan, HN; Zhang, M; Zhang, XX1
Angapelly, S; Angeli, A; Arifuddin, M; Capasso, C; Del Prete, S; Ramya, PVS; Supuran, CT1
Bua, S; Kopecka, J; Mujumdar, P; Poulsen, SA; Riganti, C; Supuran, CT1
Angeli, A; Berrino, E; Capasso, C; De Luca, L; Del Prete, S; Gitto, R; Mancuso, F; Supuran, CT1
Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS1
Aguenaou, H; Colin, DA1
MAREN, TH2
FRIEDBERG, CK; HALPERN, M; MINOR, JB; TAYMOR, R1
BELSKY, H1
BUSO, R; SABATER, J; SUAREZ, RM1
MAREN, TH; MAYER, E; WADSWORTH, BC1
BONANNO, S; REITANO, U1
ANDREUCCI, G; CORDOVA, C; COSTA, C; PALMA, G1
FISHER, ER; GLUSHIEN, AS1
COCCHI, P1
HERKEN, H; WILUTZKY, H1
ARIENS, EJ; SIMONIS, AM1
JOHNSON, MJ; MITCHELL, DF1
FORD, RV; MOYER, JH; SPURR, CL1
NOCKER, J; SCHLEUSING, G1
SALISBURY, GW; VANDEMARK, NL1
HAZARD, R; PIGNARD, P1
OTTO, H1
HEJTMANCIK, MR; HERRMANN, GR; KROETZ, FW1
RICHTERICH, R1
BARRETT, WE; PLUMMER, AJ; RUTLEDGE, RA; SHEPPARD, H1
CHART, JJ; GAUNT, R; RENZI, AA1
GROBIN, W1
GOERES, E; HILGETAG, G; JUNG, F1
AZZOLINI, G; MARRO, F1
AZZOLINI, G; GADOLINI, G; MARRO, F1
COZZALI, G; FRASCARELLI, R; LUCIDI, E1
HENTRICH, K1
FELLNER, SK1
KORE, R; MCINTOSH, HW; SERAGLIA, M; UHLEMANN, I1
ARMASCRUZ, R; GOMEZ, R; MARDONES, J; PLAZADELOSREYES, M1
HIRASAWA, Y; KINOSHITA, Y1
LASSEN, JB; NIELSEN, OE1
CASTLES, TR; WILLIAMSON, HE1
IASTREBOVA, LP; KIRPISHCHIKOVA, TP1
Demir, N; Demir, Y; Nadaroğlu, H1
Dincer, B; Karahalil, F; Kolayli, S; Sahin, H; Supuran, CT1
Scozzafava, A; Supuran, CT1
Al-Rashida, M; Hamayoun, M; Iqbal, J; Mumtaz, A; Saeed, A1
Berg, S; Isupov, MN; James, P; Kotlar, HK; Lioliou, M; Littlechild, JA; Saneei, V; Sayer, C1
Supuran, CT2
Angeli, A; Bucolo, F; Capasso, C; De Luca, L; De Luca, V; Gitto, R; Mancuso, F; Supuran, CT1
Aisala, H; Aspatwar, A; Bonardi, A; Lumme, J; Parkkila, S; Primmer, CR; Supuran, CT; Zueva, K1
Angeli, A; Paoletti, N; Supuran, CT1

Reviews

6 review(s) available for sulfanilamide and acetazolamide

ArticleYear
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole

2021
[PROGRESS OF CARBONIC ANHYDRASE INHIBITORS].
    [Sogo rinsho] Clinic all-round, 1964, Volume: 13

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dogs; Enzyme Inhibitors; Pharmacology; Research; Sulfanilamide; Sulfanilamides; Sulfonamides

1964
Glaucoma and the applications of carbonic anhydrase inhibitors.
    Sub-cellular biochemistry, 2014, Volume: 75

    Topics: Acetazolamide; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Carbonic Anhydrases; Glaucoma; Humans; Intraocular Pressure; Nitric Oxide; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiazines

2014
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
    Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:4

    Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Celecoxib; Clinical Trials as Topic; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Isoxazoles; Methazolamide; Phenobarbital; Sulfanilamide; Sulfanilamides; Sulfonamides; Sulfonic Acids; Thiazines; Thiophenes; Topiramate; Zonisamide

2016
Carbonic anhydrase inhibition and the management of neuropathic pain.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:8

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Neuralgia; Sulfanilamide; Sulfanilamides

2016
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
    Molecules (Basel, Switzerland), 2023, Apr-04, Volume: 28, Issue:7

    Topics: Acetazolamide; Anticonvulsants; Carbonic Anhydrase Inhibitors; Dermatologic Agents; Structure-Activity Relationship; Sulfanilamide; Sulfonamides

2023

Other Studies

127 other study(ies) available for sulfanilamide and acetazolamide

ArticleYear
Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Journal of medicinal chemistry, 1999, Jul-15, Volume: 42, Issue:14

    Topics: Administration, Topical; Animals; Aqueous Humor; Benzene Derivatives; Carbonic Anhydrase Inhibitors; Cattle; Eye; Humans; Intraocular Pressure; Isoenzymes; Male; Ophthalmic Solutions; Pyridines; Rabbits; Solubility; Structure-Activity Relationship; Sulfonamides; Thiadiazoles; Tissue Distribution

1999
Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
    Journal of medicinal chemistry, 1999, Sep-09, Volume: 42, Issue:18

    Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane Permeability; Cornea; Delayed-Action Preparations; Dipeptides; Disease Models, Animal; Glaucoma; Humans; Intraocular Pressure; Isoenzymes; Models, Molecular; Rabbits; Solubility; Sulfonamides; Time Factors

1999
Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
    Journal of medicinal chemistry, 2000, Jan-27, Volume: 43, Issue:2

    Topics: Animals; Carbonic Anhydrase Inhibitors; Cattle; Cell Membrane Permeability; Cytosol; Erythrocyte Membrane; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Sulfonamides

2000
Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.
    Bioorganic & medicinal chemistry letters, 2001, Feb-26, Volume: 11, Issue:4

    Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Glaucoma; Intraocular Pressure; Pentetic Acid; Quantitative Structure-Activity Relationship; Rabbits; Sulfonamides; Zinc

2001
Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
    Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7

    Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chelating Agents; Chloroform; Chromatography, High Pressure Liquid; Cornea; DNA, Complementary; Edetic Acid; Enzyme Inhibitors; Escherichia coli; Glaucoma; Humans; Hydrogen-Ion Concentration; Imino Acids; Kinetics; Male; Models, Chemical; Nitrilotriacetic Acid; Pentetic Acid; Pressure; Rabbits; Sulfonamides; Temperature; Time Factors; Ultraviolet Rays; Water

2002
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6

    Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cattle; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Kinetics; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Sulfonamides

2003
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.
    Journal of medicinal chemistry, 2003, May-22, Volume: 46, Issue:11

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Benzene Derivatives; Bromine; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase IV; Carbonic Anhydrase IX; Carbonic Anhydrases; Chlorine; Enzyme Inhibitors; Humans; Iodine; Neoplasm Proteins; Structure-Activity Relationship; Sulfanilamides; Sulfonamides

2003
Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.
    Bioorganic & medicinal chemistry letters, 2004, Jan-05, Volume: 14, Issue:1

    Topics: Administration, Topical; Animals; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Glaucoma; Hypertension; Intraocular Pressure; Male; Monosaccharides; Rabbits; Sulfanilamides

2004
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Animals; Benzene Derivatives; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase V; Coumarins; Mice; Mitochondria; Structure-Activity Relationship; Sulfonamides; Thiadiazoles

2004
Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2004, Jun-21, Volume: 14, Issue:12

    Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Isoenzymes; Quantitative Structure-Activity Relationship; Sulfonamides

2004
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Bioorganic & medicinal chemistry letters, 2004, Jul-16, Volume: 14, Issue:14

    Topics: Amino Acid Sequence; Animals; Carbonic Anhydrase Inhibitors; Cytosol; Drug Design; Humans; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Molecular Sequence Data; Neoplasms; Rats; Structure-Activity Relationship; Sulfonamides

2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Bioorganic & medicinal chemistry letters, 2004, Nov-01, Volume: 14, Issue:21

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Sulfonamides; Triazines

2004
Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
    Bioorganic & medicinal chemistry letters, 2004, Dec-20, Volume: 14, Issue:24

    Topics: Archaea; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2004
Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
    Bioorganic & medicinal chemistry letters, 2005, Jan-17, Volume: 15, Issue:2

    Topics: Acetazolamide; Amines; Biomarkers, Tumor; Carbonic Anhydrase Inhibitors; Catalysis; Cytosol; Heterocyclic Compounds; Humans; Isoenzymes; Morpholines; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides

2005
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2005, Feb-15, Volume: 15, Issue:4

    Topics: Anticonvulsants; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Protein Subunits; Structure-Activity Relationship; Sulfonamides

2005
Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
    Bioorganic & medicinal chemistry letters, 2005, Feb-15, Volume: 15, Issue:4

    Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Cattle; Dose-Response Relationship, Drug; Humans; Isoenzymes; Kinetics; Membrane Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2005
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Bioorganic & medicinal chemistry letters, 2005, May-02, Volume: 15, Issue:9

    Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Cytosol; Humans; Kinetics; Neoplasms; Structure-Activity Relationship; Sulfonamides; Urea

2005
Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumo
    Bioorganic & medicinal chemistry letters, 2005, Jul-01, Volume: 15, Issue:13

    Topics: Antigens, Neoplasm; Boron Compounds; Boron Neutron Capture Therapy; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2005
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
    Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Fructose; Humans; Kinetics; Membrane Proteins; Protein Binding; Structure-Activity Relationship; Sulfonamides; Topiramate

2005
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

    Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Disease Models, Animal; Drug Design; Glaucoma; Intraocular Pressure; Rabbits; Structure-Activity Relationship; Sulfonamides

2005
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2005, Nov-01, Volume: 15, Issue:21

    Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Neoplasm Proteins; Structure-Activity Relationship; Sulfonamides

2005
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
    Journal of medicinal chemistry, 2005, Dec-01, Volume: 48, Issue:24

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase V; Catalysis; Cloning, Molecular; Humans; Isoenzymes; Kinetics; Mitochondria; Molecular Sequence Data; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2005
Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8

    Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Structure-Activity Relationship; Sulfonamides

2006
Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Journal of medicinal chemistry, 2006, Mar-23, Volume: 49, Issue:6

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; DNA, Bacterial; Gastric Mucosa; Gastritis; Helicobacter pylori; Humans; Molecular Sequence Data; Polymorphism, Genetic; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Sulfonic Acids

2006
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Journal of medicinal chemistry, 2007, Jan-25, Volume: 50, Issue:2

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalysis; Cloning, Molecular; DNA; Humans; Isoenzymes; Molecular Sequence Data; Protein Subunits; Sequence Homology, Amino Acid; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2007
Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Bioorganic & medicinal chemistry letters, 2007, Jul-01, Volume: 17, Issue:13

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chemistry, Pharmaceutical; Cloning, Molecular; Drug Design; Enzyme Inhibitors; Helicobacter pylori; Humans; Molecular Sequence Data; Recombinant Proteins; Sequence Homology, Amino Acid; Stomach Neoplasms; Stomach Ulcer; Sulfonamides

2007
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
    Bioorganic & medicinal chemistry, 2007, Dec-01, Volume: 15, Issue:23

    Topics: Amino Acid Sequence; Carbonic Anhydrase III; Carbonic Anhydrase Inhibitors; Cloning, Molecular; Cytosol; Enzyme Activation; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2007
Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
    Bioorganic & medicinal chemistry letters, 2008, Jan-15, Volume: 18, Issue:2

    Topics: Amines; Carbonic Anhydrase Inhibitors; Copper; Heterocyclic Compounds; Isoenzymes; Neoplasms; Sulfonamides

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
    Bioorganic & medicinal chemistry, 2009, Feb-01, Volume: 17, Issue:3

    Topics: Amino Acid Sequence; Antifungal Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Kinetics; Molecular Sequence Data; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Sulfonamides; Sulfonic Acids

2009
Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
    Journal of medicinal chemistry, 2009, Feb-12, Volume: 52, Issue:3

    Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Isoenzymes; Kidney; Mice; Protein Processing, Post-Translational

2009
Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalysis; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Humans; Molecular Sequence Data; Mycobacterium tuberculosis; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2009
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
    Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9

    Topics: Amino Acid Sequence; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Sulfonamides; Sulfonic Acids

2009
Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
    Bioorganic & medicinal chemistry, 2009, Jul-01, Volume: 17, Issue:13

    Topics: Amino Acid Sequence; Antifungal Agents; Bacterial Proteins; Candida albicans; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cryptococcus neoformans; Helicobacter pylori; Humans; Models, Molecular; Molecular Sequence Data; Protein Binding; Protein Conformation; Sequence Alignment; Structure-Activity Relationship; Sulfonamides

2009
Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14

    Topics: Amino Acid Sequence; Animals; Anthozoa; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Molecular Sequence Data; Molecular Structure; Recombinant Proteins; Sequence Alignment; Sulfonamides

2009
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
    Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Drug Design; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship

2009
Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cytosol; Humans; Isoenzymes; Mitochondria; Molecular Structure; Phenols; Structure-Activity Relationship

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Journal of medicinal chemistry, 2010, Jan-28, Volume: 53, Issue:2

    Topics: Acetamides; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Crystallography, X-Ray; Humans; Lacosamide; Structure-Activity Relationship

2010
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
    Journal of medicinal chemistry, 2010, Mar-11, Volume: 53, Issue:5

    Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Cloning, Molecular; DNA, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Sequence Alignment; Sequence Analysis, DNA; Structure-Activity Relationship; Sulfonamides

2010
Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides.
    Bioorganic & medicinal chemistry letters, 2010, Apr-01, Volume: 20, Issue:7

    Topics: Amino Acid Sequence; Brucella suis; Carbohydrates; Carbonic Anhydrase I; Carbonic Anhydrase Inhibitors; Humans; Kinetics; Molecular Sequence Data; Sequence Alignment; Structure-Activity Relationship; Sulfanilamides; Water

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
    Bioorganic & medicinal chemistry, 2010, Aug-01, Volume: 18, Issue:15

    Topics: Amino Acid Sequence; Amino Acid Substitution; Asparagine; Binding Sites; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cell Line, Tumor; Computer Simulation; Humans; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Sulfonamides

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides.
    Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1

    Topics: Benzenesulfonamides; Candida albicans; Carbonic Anhydrase II; Enzyme Inhibitors; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides

2011
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
    Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2

    Topics: Animals; Anions; Anthozoa; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Structure-Activity Relationship; Sulfonamides

2011
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
    Bioorganic & medicinal chemistry, 2011, Feb-01, Volume: 19, Issue:3

    Topics: Anti-Bacterial Agents; Brucella suis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Drug Design; Drug Discovery; Inhibitory Concentration 50; Kinetics; Sulfonamides; Sulfonic Acids

2011
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.
    Journal of medicinal chemistry, 2011, Mar-24, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Antifungal Agents; Biological Products; Candida albicans; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Cryptococcus neoformans; Crystallography, X-Ray; Humans; Hydrogen Bonding; Isoenzymes; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Phenols; Protein Binding; Small Molecule Libraries

2011
Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Bioorganic & medicinal chemistry letters, 2011, May-15, Volume: 21, Issue:10

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Boron Compounds; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Enzyme Activation; Humans; Molecular Structure; Neoplasm Proteins; Oxazolidinones; Protein Isoforms; Structure-Activity Relationship; Sulfonamides

2011
Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
    Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16

    Topics: Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Salmonella Infections; Salmonella typhimurium; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2011
Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.
    Journal of enzyme inhibition and medicinal chemistry, 2012, Volume: 27, Issue:4

    Topics: Acridines; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2012
Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

    Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Drug Screening Assays, Antitumor; Humans; Isoenzymes; Molecular Targeted Therapy; Neoplasms; Stereoisomerism; Structure-Activity Relationship; Sulfonamides

2011
Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.
    Journal of enzyme inhibition and medicinal chemistry, 2012, Volume: 27, Issue:6

    Topics: Benzenesulfonates; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Electrophoresis, Polyacrylamide Gel; Enzyme Assays; Erythrocytes; Humans; Kinetics; Molecular Mimicry; Molecular Structure; Structure-Activity Relationship; Substrate Specificity; Sulfapyridine; Sulfonamides

2012
Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
    Bioorganic & medicinal chemistry, 2012, Feb-15, Volume: 20, Issue:4

    Topics: Amino Acid Sequence; Animals; Carbonic Anhydrases; Cloning, Molecular; Fossils; Humans; Molecular Sequence Data; Porifera; Protein Binding; Sequence Alignment; Sulfonamides; Sulfonic Acids

2012
Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases.
    Bioorganic & medicinal chemistry, 2012, Apr-01, Volume: 20, Issue:7

    Topics: Carbohydrates; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Glycoconjugates; Humans; Protein Isoforms; Solubility; Sulfonamides; Thiourea

2012
Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors.
    Bioorganic & medicinal chemistry, 2012, Apr-01, Volume: 20, Issue:7

    Topics: Amino Acid Sequence; Amino Acid Substitution; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Sulfonamides

2012
Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
    Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Dermatomycoses; Fungal Proteins; Humans; Isoenzymes; Malassezia; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Recombinant Fusion Proteins; Scalp Dermatoses; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2012
The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.
    Bioorganic & medicinal chemistry, 2013, Mar-15, Volume: 21, Issue:6

    Topics: Amino Acid Sequence; Bacteria; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Protein Binding; Recombinant Proteins; Sequence Alignment; Sulfonamides

2013
DNA cloning, characterization, and inhibition studies of an α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
    Journal of medicinal chemistry, 2012, Dec-13, Volume: 55, Issue:23

    Topics: Amino Acid Sequence; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; DNA; Electrophoresis, Polyacrylamide Gel; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Vibrio cholerae

2012
Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
    Journal of medicinal chemistry, 2013, Feb-28, Volume: 56, Issue:4

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chagas Disease; Cloning, Molecular; Humans; Molecular Sequence Data; Phylogeny; Protozoan Proteins; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfonamides; Thiadiazoles; Trypanocidal Agents; Trypanosoma cruzi

2013
Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides.
    Bioorganic & medicinal chemistry letters, 2013, May-01, Volume: 23, Issue:9

    Topics: Acetazolamide; Amino Acid Sequence; Antifungal Agents; Candida glabrata; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Protein Binding; Sequence Alignment; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids

2013
Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
    European journal of medicinal chemistry, 2013, Volume: 66

    Topics: Antineoplastic Agents; Apoptosis; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Chemistry Techniques, Synthetic; Coumarins; Drug Design; Humans; Isoenzymes; MCF-7 Cells; Melanoma, Experimental; Molecular Docking Simulation; Protein Conformation; Quantitative Structure-Activity Relationship; Substrate Specificity; Sulfonamides

2013
Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis.
    Journal of medicinal chemistry, 2013, Sep-26, Volume: 56, Issue:18

    Topics: Amino Acid Sequence; Antiprotozoal Agents; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Leishmania infantum; Leishmaniasis; Molecular Sequence Data

2013
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
    Bioorganic & medicinal chemistry, 2014, Jan-01, Volume: 22, Issue:1

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Humans; Models, Molecular; Protein Isoforms; Structure-Activity Relationship

2014
Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
    Bioorganic & medicinal chemistry letters, 2014, Jan-01, Volume: 24, Issue:1

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diatoms; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2014
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis.
    Bioorganic & medicinal chemistry letters, 2014, Jan-01, Volume: 24, Issue:1

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Porphyromonas gingivalis; Structure-Activity Relationship; Sulfonamides

2014
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties.
    Bioorganic & medicinal chemistry letters, 2014, Apr-01, Volume: 24, Issue:7

    Topics: Butanones; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Imidazoles; Molecular Structure; Structure-Activity Relationship; Sulfanilamides; Thiones; Thiourea

2014
Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.
    Bioorganic & medicinal chemistry, 2014, May-15, Volume: 22, Issue:10

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Schiff Bases; Structure-Activity Relationship; Sulfonamides

2014
Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
    Bioorganic & medicinal chemistry, 2014, Jun-01, Volume: 22, Issue:11

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Legionella pneumophila; Molecular Sequence Data; Molecular Structure; Sequence Alignment; Structure-Activity Relationship; Sulfonamides

2014
Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Sequence Data; Molecular Structure; Phylogeny; Porphyromonas gingivalis; Structure-Activity Relationship; Sulfonamides

2014
Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
    Bioorganic & medicinal chemistry, 2015, Feb-01, Volume: 23, Issue:3

    Topics: Antimalarials; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Plasmodium falciparum; Structure-Activity Relationship; Sulfonamides

2015
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
    Bioorganic & medicinal chemistry, 2015, Apr-15, Volume: 23, Issue:8

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Molecular Sequence Data; Nostoc commune; Sequence Alignment; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiazines; Thiophenes

2015
The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides.
    Bioorganic & medicinal chemistry, 2015, May-15, Volume: 23, Issue:10

    Topics: Amino Acid Sequence; Animals; Anopheles; Baculoviridae; Bicarbonates; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Gene Expression; High-Throughput Screening Assays; Insect Proteins; Insecticides; Kinetics; Molecular Sequence Data; Phylogeny; Protons; Recombinant Proteins; Sequence Alignment; Sf9 Cells; Spodoptera; Sulfanilamides

2015
Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.
    Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Molecular Structure; Phylogeny; Streptococcus mutans; Sulfonamides

2015
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
    Bioorganic & medicinal chemistry letters, 2015, Sep-01, Volume: 25, Issue:17

    Topics: Acclimatization; Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cold Temperature; Humans; Molecular Sequence Data; Phylogeny; Pseudoalteromonas; Sequence Alignment; Sulfonamides

2015
Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
    Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2

    Topics: Anti-Bacterial Agents; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Gammaproteobacteria; Molecular Docking Simulation; Sulfonamides

2016
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
    Bioorganic & medicinal chemistry letters, 2016, Feb-15, Volume: 26, Issue:4

    Topics: Alteromonadaceae; Anti-Bacterial Agents; Bacterial Proteins; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Phylogeny; Protein Binding; Sulfanilamide; Sulfanilamides

2016
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
    Bioorganic & medicinal chemistry, 2016, Mar-01, Volume: 24, Issue:5

    Topics: Amino Acid Sequence; Base Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cholera; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Sulfonamides; Vibrio cholerae

2016
Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
    Bioorganic & medicinal chemistry letters, 2016, Apr-01, Volume: 26, Issue:7

    Topics: Acetazolamide; Benzenesulfonamides; Carbonic Anhydrase I; Carbonic Anhydrase Inhibitors; Enterobacter; Enterobacteriaceae Infections; Humans; Methazolamide; Structure-Activity Relationship; Sulfonamides

2016
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
    Bioorganic & medicinal chemistry letters, 2016, Apr-15, Volume: 26, Issue:8

    Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship; Sulfonamides; Vibrio cholerae

2016
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
    Bioorganic & medicinal chemistry letters, 2016, 09-01, Volume: 26, Issue:17

    Topics: Amino Acid Sequence; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Humans; Kinetics; Molecular Sequence Data; Plasmodium falciparum; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Sequence Alignment; Structure-Activity Relationship; Sulfonamides

2016
Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.
    European journal of medicinal chemistry, 2017, May-26, Volume: 132

    Topics: Antineoplastic Agents; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cinnamates; Drug Design; Glucosamine; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Molecular Docking Simulation; Protein Binding; Structure-Activity Relationship

2017
Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
    Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20

    Topics: Amides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Enzyme Activation; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2017
Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma.
    Journal of medicinal chemistry, 2019, 04-25, Volume: 62, Issue:8

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Survival; Drug Design; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Mice; Mice, Nude; Protein Isoforms; Structure-Activity Relationship; Temozolomide; Transplantation, Heterologous; Tumor Cells, Cultured

2019
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in
    ACS medicinal chemistry letters, 2020, Nov-12, Volume: 11, Issue:11

    Topics:

2020
Subcellular distribution of carbonic anhydrase in the enterocyte of the rabbit ileum and the Caco-2 cell. Evidence for the presence of two isozymes bound to brush-border membranes.
    Biochimica et biophysica acta, 1992, Aug-10, Volume: 1109, Issue:1

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane; Ileum; Male; Microvilli; Polyethylene Glycols; Rabbits; Sulfanilamide; Sulfanilamides; Temperature; Tumor Cells, Cultured

1992
Pharmacological and renal effects of diamox (6063), a new carbonic anhydrase inhibitor.
    Transactions of the New York Academy of Sciences, 1952, Volume: 15, Issue:2

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Hydro-Lyases; Kidney; Sulfanilamide; Sulfanilamides; Sulfonamides

1952
The use of diamox, a carbonic anhydrase inhibitor, as an oral diuretic in patients with congestive heart failure.
    The New England journal of medicine, 1953, May-21, Volume: 248, Issue:21

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diuretics; Heart Failure; Hydro-Lyases; Sulfanilamide; Sulfanilamides; Sulfonamides

1953
Use of a new oral diuretic, diamox, in congestive heart failure.
    The New England journal of medicine, 1953, Jul-23, Volume: 249, Issue:4

    Topics: Acetazolamide; Diuretics; Heart Failure; Hydro-Lyases; Sulfanilamide; Sulfanilamides; Sulfonamides

1953
[Diamox; a new non-mercurial diuretic for oral administration; clinical observations on the treatment of edema due to cardiac failure].
    Boletin de la Asociacion Medica de Puerto Rico, 1953, Volume: 45, Issue:10

    Topics: Acetazolamide; Administration, Oral; Diuretics; Edema; Heart Diseases; Heart Failure; Humans; Sulfanilamide; Sulfanilamides; Sulfonamides

1953
Carbonic anhydrase inhibition. I. The pharmacology of diamox 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide.
    Bulletin of the Johns Hopkins Hospital, 1954, Volume: 95, Issue:5

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diuretics; Hydro-Lyases; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiadiazoles

1954
[Clearance tests of kidney function in patients treated with 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox)].
    La Riforma medica, 1955, Oct-01, Volume: 69, Issue:40

    Topics: Acetazolamide; Diuretics; Hydro-Lyases; Kidney Function Tests; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiadiazoles

1955
[Variations of urinary pH of R.A. during 2-acetamido-1, 3, 4-thiadiazole-6-sulfonamide (diamox) therapy of cardiac insufficiency].
    Minerva medica, 1955, Sep-29, Volume: 46, Issue:78

    Topics: Acetazolamide; Diuretics; Heart Failure; Humans; Hydro-Lyases; Hydrogen-Ion Concentration; Sulfanilamide; Sulfanilamides; Sulfonamides

1955
Renal lesions of sulfonamide type after treatment with acetazolamide (diamox).
    Journal of the American Medical Association, 1956, Jan-21, Volume: 160, Issue:3

    Topics: Acetazolamide; Diuretics; Hodgkin Disease; Hydro-Lyases; Kidney; Sulfanilamide; Sulfanilamides; Sulfonamides

1956
[Clinical uses of 5-acetamido-1, 3, 4-thiadiazole-2-sulfonamide (diamox)].
    Rivista di clinica pediatrica, 1955, Volume: 56, Issue:2

    Topics: Acetazolamide; Diuretics; Hydro-Lyases; Sulfanilamide; Sulfanilamides; Sulfonamides

1955
[The effect of 5-acetamido-1, 3, 4-thiadiazole-2-sulfonamide (diamox) on sodium balance and water excretion in cardiac edema].
    Deutsches Archiv fur klinische Medizin, 1955, Volume: 202, Issue:4

    Topics: Acetazolamide; Body Fluids; Diuretics; Edema, Cardiac; Heart Failure; Hydro-Lyases; Sodium; Sulfanilamide; Sulfanilamides; Sulfonamides; Water

1955
[Sulfonamide therapy of non-infectious diseases].
    Nederlands tijdschrift voor geneeskunde, 1957, Feb-09, Volume: 101, Issue:6

    Topics: Acetazolamide; Sulfanilamide; Sulfanilamides; Sulfonamides; Urea

1957
Effect of 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox) on dental caries resistance in hamsters.
    Journal of dental research, 1957, Volume: 36, Issue:3

    Topics: Acetazolamide; Animals; Cricetinae; Dental Caries; Dental Caries Susceptibility; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiadiazoles

1957
The problem of bioassay and comparative potency of diuretics. II. Carbonic anhydrase inhibitors as oral diuretics.
    Circulation, 1957, Volume: 16, Issue:3

    Topics: Acetazolamide; Benzoates; Biological Assay; Carbonic Anhydrase Inhibitors; Diuretics; Humans; Sulfanilamide; Sulfanilamides; Sulfonamides

1957
[Clinical experiences with mercury-free diuretics. II. Experiences with 2-acetylamino-1, 3, 4-thiadiazol-5-sulfonamide (nephramid)].
    Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1957, Volume: 17, Issue:3

    Topics: Acetazolamide; Diuretics; Edema; Humans; Mercury; Sulfanilamide; Sulfanilamides; Sulfonamides

1957
Sulfa compounds in reversible inhibition of sperm metabolism by carbon dioxide.
    Science (New York, N.Y.), 1957, Nov-29, Volume: 126, Issue:3283

    Topics: Acetazolamide; Carbohydrate Metabolism; Carbohydrates; Carbon Dioxide; Male; Spermatozoa; Sulfanilamide; Sulfanilamides

1957
[Sulfonamide inhibitors of tubular function, carbonic anhydrase inhibitors & hypoglycemics].
    Actualites pharmacologiques, 1957, Volume: 10

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Humans; Hypoglycemic Agents; Probenecid; Sulfanilamide; Sulfanilamides; Sulfonamides

1957
[A new sulfonamide diuretic: chlorothiazide].
    Il Policlinico. Sezione pratica, 1958, Apr-07, Volume: 65, Issue:14

    Topics: Acetazolamide; Chlorothiazide; Diuretics; Sulfanilamide; Sulfanilamides; Sulfonamides

1958
[Effect of the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (acetazolamide) on citric acid excretion in the urine].
    Klinische Wochenschrift, 1958, Jul-01, Volume: 36, Issue:13

    Topics: Acetazolamide; Body Fluids; Carbonic Anhydrase Inhibitors; Citrates; Citric Acid; Humans; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiadiazoles

1958
Clinical evaluation of Su-5879 (esidrix), a new oral sulfonamide diuretic; preliminary report.
    Texas state journal of medicine, 1958, Volume: 54, Issue:12

    Topics: Acetazolamide; Diuretics; Hydrochlorothiazide; Sulfanilamide; Sulfanilamides; Sulfonamides

1958
[Experimental-clinical studies on hydrochlorothiazide (esidrex) a new diuretically effective sulfonamide].
    Klinische Wochenschrift, 1959, Apr-01, Volume: 37, Issue:7

    Topics: Acetazolamide; Biomedical Research; Diuretics; Hydrochlorothiazide; Sulfanilamide; Sulfanilamides; Sulfonamides

1959
The pharmacology of hydrochlorothiazide (esidrix) a new, orally effective sulfonamide diuretic.
    Toxicology and applied pharmacology, 1959, Volume: 1, Issue:4

    Topics: Acetazolamide; Diuretics; Hydrochlorothiazide; Sulfanilamide; Sulfanilamides; Sulfonamides

1959
Sulfonamide compounds with high diuretic activity.
    Toxicology and applied pharmacology, 1959, Volume: 1, Issue:4

    Topics: Acetazolamide; Diuretics; Electrolytes; Sulfanilamide; Sulfanilamides; Sulfonamides; Water

1959
Hydrochlorothiazide; a new sulfonamide diuretic.
    Canadian Medical Association journal, 1959, Aug-01, Volume: 81, Issue:3

    Topics: Acetazolamide; Diuretics; Hydrochlorothiazide; Sulfanilamide; Sulfanilamides; Sulfonamides

1959
[Experimental studies on the anticonvulsive effect of acetazolamide, its derivatives and some sulfonamides].
    Acta physiologica Academiae Scientiarum Hungaricae, 1961, Volume: 19

    Topics: Acetazolamide; Anticonvulsants; Sulfanilamide; Sulfanilamides; Sulfonamides

1961
[Mechanism of action of some sulfonamide diuretics (acetazolamide, chlorothiazide and K-572). Experimental research on man].
    Rivista di biologia, 1960, Volume: 53

    Topics: Acetazolamide; Chlorothiazide; Diuretics; Humans; Male; Sulfanilamide; Sulfanilamides; Sulfonamides

1960
[Acid-base equilibrium of the blood and renal function in the man subjected to a single administration of chlorothiazide or of K-572, carried out after 3 days of acetazolamide pretreatment].
    Bollettino della Societa italiana di biologia sperimentale, 1959, Dec-31, Volume: 35

    Topics: Acetazolamide; Acid-Base Equilibrium; Chlorothiazide; Diuretics; Humans; Kidney; Male; Sulfanilamide; Sulfanilamides; Sulfonamides

1959
[The influence of diuretics of the sulfonamide type on the urinary excretion of uric acid and on the blood level of uric acid].
    Minerva medica, 1960, May-26, Volume: 51

    Topics: Acetazolamide; Chlorothiazide; Diuretics; Humans; Sulfanilamide; Sulfanilamides; Sulfonamides; Uric Acid

1960
The relation between enzyme inhibition and physiological response in the carbonic anhydrase system.
    The Journal of pharmacology and experimental therapeutics, 1963, Volume: 139

    Topics: Acetazolamide; Carbonic Anhydrases; Chlorothiazide; Hydrochlorothiazide; Sulfanilamide; Sulfanilamides

1963
[ON THE PAPER CHROMATOGRAPHIC DISTINCTIONS OF SULFONAMIDE DIURETICS AND SULFONAMIDES WITH OTHER AREAS OF INDICATIONS].
    Die Pharmazie, 1963, Volume: 18

    Topics: Acetazolamide; Antineoplastic Agents; Carbutamide; Chlorothiazide; Chromatography; Diuretics; Hydrochlorothiazide; Research; Sulfacetamide; Sulfamerazine; Sulfamethoxypyridazine; Sulfanilamide; Sulfanilamides; Sulfathiazoles; Sulfonamides; Tolbutamide

1963
ZINC-FREE PLANT CARBONIC ANHYDRASE; LACK OF INHIBITION BY SULFONAMIDES.
    Biochimica et biophysica acta, 1963, Sep-03, Volume: 77

    Topics: Acetazolamide; Carbonic Anhydrases; Chemical Phenomena; Chemistry; Cobalt; Cysteine; Edetic Acid; Research; Sulfanilamide; Sulfanilamides; Sulfonamides; Zinc

1963
EFFECT OF ACETAZOLAMIDE AND TRIPLE SULFONAMIDE ON CITRATE AND CALCIUM EXCRETION.
    Canadian Medical Association journal, 1963, Dec-28, Volume: 89

    Topics: Acetazolamide; Calcium; Calcium, Dietary; Citrates; Citric Acid; Humans; Sulfacetamide; Sulfadiazine; Sulfamerazine; Sulfanilamide; Sulfanilamides; Sulfonamides; Time; Toxicology; Urinary Calculi; Urine

1963
[NATRIURETIC DRUGS].
    Revista medica de Chile, 1963, Volume: 91

    Topics: Acetazolamide; Aldosterone; Ascites; Chlorothiazide; Dexamethasone; Diabetes Insipidus; Diuresis; Diuretics; Heart Failure; Hydrochlorothiazide; Hydroflumethiazide; Hypertension; Kidney Tubules; Metyrapone; Mineralocorticoid Receptor Antagonists; Natriuresis; Pharmacology; Physiology; Spironolactone; Sulfanilamide; Sulfanilamides; Thiazines

1963
TRIAMTERENE ACTIVITY INVESTIGATED BY THE STOP-FLOW TECHNIQUE AND IN VITRO STUDIES ON CARBONIC ANHYDRASE.
    Acta pharmacologica et toxicologica, 1963, Volume: 20

    Topics: Acetazolamide; Ammonia; Animals; Carbonic Anhydrases; Chlorothiazide; Diuretics; In Vitro Techniques; Kidney Tubules; Pharmacology; Potassium; Research; Sulfanilamide; Sulfanilamides; Swine; Triamterene

1963
COMPARISON OF THE DIURETIC ACTIVITIES OF BENZIMIDAZOLYL-TOLUENESULFANAMIDE COMPOUNDS AND ACETAZOLAMIDE.
    Journal of pharmaceutical sciences, 1964, Volume: 53

    Topics: Acetazolamide; Diuretics; Pharmacology; Rats; Research; Sulfanilamide; Sulfanilamides; Sulfonamides

1964
[Clinical studies on a new sulfonamide diuretic - diacarb].
    Terapevticheskii arkhiv, 1959, Volume: 31

    Topics: Acetazolamide; Biomedical Research; Diuretics; Sulfanilamide; Sulfanilamides; Sulfonamides

1959
Purification and some properties of carbonic anhydrase from Elephas trogontherii (Steppe elephant) bone.
    Indian journal of biochemistry & biophysics, 2007, Volume: 44, Issue:4

    Topics: Acetazolamide; Animals; Bone and Bones; Carbonic Anhydrases; Elephants; Hydrogen-Ion Concentration; Isoenzymes; Sodium Azide; Sulfanilamide; Sulfanilamides; Thiocyanates

2007
Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti.
    Journal of enzyme inhibition and medicinal chemistry, 2011, Volume: 26, Issue:6

    Topics: Acetazolamide; Animals; Carbonic Anhydrases; Dose-Response Relationship, Drug; Endangered Species; Enzyme Inhibitors; Erythrocytes; Fishes; Humans; Kinetics; Pesticides; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides

2011
Carbonic anhydrase inhibition by 1-aroyl-3-(4-aminosulfonylphenyl)thioureas.
    Journal of enzyme inhibition and medicinal chemistry, 2014, Volume: 29, Issue:6

    Topics: Acetazolamide; Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cattle; Isothiocyanates; Molecular Docking Simulation; Molecular Structure; Solutions; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides; Thiourea

2014
The structure of a tetrameric α-carbonic anhydrase from Thermovibrio ammonificans reveals a core formed around intermolecular disulfides that contribute to its thermostability.
    Acta crystallographica. Section D, Biological crystallography, 2014, Volume: 70, Issue:Pt 10

    Topics: Acetazolamide; Bacteria; Bacterial Proteins; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Cloning, Molecular; Crystallography, X-Ray; Disulfides; Enzyme Stability; Kinetics; Models, Molecular; Nitrophenols; Protein Conformation; Sulfanilamide; Sulfanilamides; Temperature

2014
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae.
    Archiv der Pharmazie, 2022, Volume: 355, Issue:10

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfanilamide; Sulfonamides; Vibrio cholerae

2022
Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite
    Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Methazolamide; Parasites; Platyhelminths; Salmon; Structure-Activity Relationship; Sulfanilamide; Sulfonamides

2023